Skip to main content

SURI

Simplify Propel Opportunities ETF

as of 04/12/2024

NAV

$ 23.14

NAV Change

- $ 0.53 /2.24%

Price

$ 23.16

Price Change

- $ 0.41 /1.74%
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation.

The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.

Fund Overview

As of 04/12/2024

Ticker Symbol
SURI
Gross Expense Ratio
2.76%
Net Expense Ratio
2.51%
CUSIP
82889N624
Total Assets
$99,979,232.85
Shares Outstanding
4,320,001
Distribution Yield as of 03/31/2024 Distribution yield calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution yield.
Distribution Yield Close
Distribution yield calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution yield.
10.69%
Distribution Frequency
Quarterly
SEC 30-Day Yield as of 03/31/2024 SEC 30-day Yield is available once fund has a full quarter of performance.
SEC 30-Day Yield Close
SEC 30-day Yield is available once fund has a full quarter of performance.
0.73%
Unsubsidized 30-Day SEC Yield as of 03/31/2024
0.49%
Options Available
No
Inception Date
02/07/2023
Premium/Discount (%) as of 04/12/2024
0.07%
NAV Per Share as of 04/12/2024
$23.14
Market Price as of 04/12/2024
$23.16
30-Day Median Bid-Ask Spread
0.76%
Bid/Ask
$22.98/$23.30
Midpoint Price
$23.14
Volume
851
NAV Symbol
SURI.NV
IOPV Symbol
SURI.IV
Shares Out. Symbol
SURI.SO
Schedule K-1
No

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees1 2.75%
Distribution and Service (12b-1) Fees 0.00%
Other Expenses2 0.00%
Acquired Fund Fees and Expenses3 0.01%
Total Annual Fund Operating Expenses 2.76%
Fee Waiver4 (0.25)%
Total Annual Fund Operating Expenses After Fee Waiver 2.51%
1. Estimated for the Fund’s initial fiscal year. The Fund has agreed to pay the adviser as compensation under a management agreement a monthly advisory fee (as a percentage of daily net assets) computed at the annual rate of 2.75% on assets up to $1 billion; 2.50% on assets over $1 billion and less than $5 billion; 2.00% on assets over $5 billion and less than $10 billion; and 1.00% on assets over $10 billion.

2. Other Expenses are estimated for the Fund’s initial fiscal year.

3. Acquired Fund Fees and Expenses, are estimated for the Fund’s initial fiscal year, are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights located in the prospectus because the financial statements include only the direct operating expenses incurred by the Fund.

4. The adviser and sub-adviser have collectively agreed to waive 0.25% of the management and sub-advisory fee on an annualized basis through December 31, 2024. This waiver may be terminated by the Fund’s Board of Trustees on 60 days’ notice and terminates automatically if the management agreement or sub-advisory agreement is terminated.

Fund Performance

As of 03/31/2024 12/31/2023

Cumulative 1 Month 3 Month 6 Month YTD 1 Year Since Inception
NAV 0.38% 26.47% 34.26% 26.47% 46.15% 20.99%
Market Price 0.47% 26.78% 34.62% 26.78% 46.80% 22.97%
Annualized 1 Year 3 Year Since Inception
NAV 46.15% 18.15%
Market Price 46.80% 19.89%
Cumulative 1 Year Since Inception
NAV 46.15% 20.99%
Market Price 46.80% 22.97%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV 46.15% 18.15%
Market Price 46.80% 19.89%

Historical Premium/Discount

Calendar Year 2023 1st Quarter of 2024
Days Traded at Premium
97
50
Days Traded at Discount
128
11

Portfolio Holdings

Ticker Name Quantity Weight
TELSAT Telesat Canada / Telesat LLC 2700000 1.42%
TELSAT TELESAT CANADA/TELESAT L 6.5 10/15/2027 4124000 1.31%
HIGH Simplify Enhanced Income ETF 91471 2.23%
KYN KAYNE ANDE COM STK USD0.001 147033 1.41%
LQD ISHARES IBOXX INV GR CORP BD 4456 0.47%
MBB ISHARES BARCLAYS MBS BOND FD 22400 2.03%
- CHINOOK THERAPEUTICS INC CVR 25000 0.01%
ACHV ACHV 217845 0.95%
AKRO Akero Therapeutics Inc 229777 5.10%
APLT APPLIED THERAPEUTICS INC 2817505 14.54%
ARDX ARDELYX INC USD 0.000001 350000 2.47%
ATHA ATHIRA PHARMA INC USD 0.0001 1492792 3.64%
CYBN CYBIN INC 500000 0.18%
DAWN DAY ONE BIOPHARMACEUTICALS I 175018 2.41%
EIGRQ EBPI MERGER INC USD 0.0001 90000 0.18%
FULC Fulcrum Therapeutics Inc 465000 3.49%
KURA Kura Oncology Inc 80000 1.56%
KYMR KYMERA THERAPEUTICS INC 30515 1.09%
MDGL Madrigal Pharmaceuticals Inc 23294 5.51%
MIRM Mirum Pharmaceuticals Inc 70000 1.72%
MRNS MARINUS PHARMACEUTICALS INC NPV 150000 1.13%
PAGP Plains GP Holdings LP 1372360 25.75%
PHAT Phathom Pharmaceuticals Inc 521935 5.29%
RNA AVIDITY BIOSCIENCES INC 125000 3.01%
SNDX Syndax Pharmaceuticals Inc 50000 1.09%
STRO Sutro Biopharma Inc 120000 0.50%
TCRX TCRX 1046916 8.12%
TRVI Trevi Therapeutics Inc 200000 0.58%
TSAT Telesat Corp 290781 2.31%
XFOR XFOR 400000 0.54%
- Estimated Cash -34966 -0.03%

Recent Distributions

Recent Distribution Disclosure

This Fund is required to meet the reporting requirement of Section 19(a) of the Investment Company Act of 1940 where the payment of any distribution is to be accompanied by a written notice that discloses the sources of a payment if it is made from any source other than the Fund's net income. Section 19(a) notices are typically released after a Fund's dividend declaration date. As such, the reported distribution details below are subject to change without notice.

Ex-Dividend Date Record Date Payable Date Ordinary Income Short Term Capital Gains Long Term Capital Gains Return of Capital Total Distribution
$0.68000 $0.00000 $0.00000 $0.00000 $0.68000
$0.03500 $0.00000 $0.00000 $0.64500 $0.68000
$0.02880 $0.00000 $0.00000 $0.65120 $0.68000
$0.68000 $0.00000 $0.00000 $0.00000 $0.68000
$1.00000 $0.00000 $0.00000 $0.00000 $1.00000
View Distribution History

Register for Simplify's Investor Hub

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
  • Stay up-to-date with our latest thoughts on markets via our weekly market commentaries
Create Your Account
Register Info
Contact Us